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EXPERIMENTAL STUDIES
Hypothermic, Closed Circuit Pericardioperfusion: A Potential
Cardioprotective Technique in Acute Regional Ischemia
RAVI H. DAVE, MD, SHARON L. HALE, BS, ROBERT A. KLONER, MD, PHD, FACC
Los Angeles, California
Objectives. This study sought to determine whether infarct size
can be reduced by hypothermic pericardioperfusion.
Background. We have shown that myocardial infarct size can be
reduced by topical cooling of the heart. The present study tests
whether myocardial cooling and protection can be produced by
hypothermic pericardioperfusion using a catheter.
Methods. The catheter was sutured into the pericardial space of
anesthetized rabbits. Beginning 30 min before coronary artery
occlusion, the space was perfused with either chilled (n 5 10) or
body temperature (n 5 10) fluid. The artery was occluded for
30 min and reperfused for 3 h.
Results. After 30 min of pericardioperfusion, myocardial tem-
perature was reduced to 34.1 6 0.9°C in chilled hearts compared
with 38.9 6 0.4°C in control hearts, p < 0.001, a reduction in
myocardial temperature of ;5°C. Risk areas were similar in both
groups (32 6 4% left ventricle in cooled and 31 6 3% in control
hearts, p 5 NS). However, infarct size in cooled hearts was
significantly reduced by 49% (18 6 3% of risk area vs. 35 6 6%,
p 5 0.025). Tamponade did not develop, and there were no
significant differences in heart rate, arterial pressure or body
temperature between groups.
Conclusions. A significant reduction in myocardial tempera-
ture, without the development of cardiac tamponade, can be
attained using a pericardial catheter to cool the pericardial space.
This reduction in temperature causes a significant reduction in
necrotic damage. This technique might be used to cool and protect
the heart as an adjunct to thrombolysis or during minimally
invasive cardiac surgery.
(J Am Coll Cardiol 1998;31:1667–71)
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Several recent animal studies have demonstrated the protec-
tive role of hypothermia in the setting of acute regional
ischemia, reducing necrosis in the myocardium (1–9). Data
from two studies in rabbits in our laboratory have shown that
reducing myocardial temperature by direct local cooling of the
surface of the heart, either before or early after coronary artery
occlusion, results in a profound reduction in infarct size (8,9).
Although this method was very effective in producing hypo-
thermia and reducing infarct size, it has limited clinical appli-
cation.
The pericardial space has been proposed as a site of
delivery of agents to the heart. One advantage of this route of
administration is an enhanced local effect with reduced sys-
temic effects. Hypothermia induced by this technique might be
beneficial in reducing necrosis and providing myocardial pro-
tection in patients undergoing acute myocardial infarction or
in patients with coronary artery disease undergoing bypass
surgery without extracorporeal circulation.
In the present study we investigated the ability of a specially
designed pericardial catheter to deliver coolant to the pericar-
dial space and to reduce myocardial temperature before
coronary artery occlusion in rabbits. We also studied the
influence of this intervention on myocardial infarct size.
Methods
The rabbits used in the present study were maintained in
accordance with the policies and guidelines of the Position of
the American Heart Association on research animal use and
the Committee on Care and Use of Laboratory Animals of the
Institute of Laboratory Animal Resources, National Research
Council (Department of Health, Education and Welfare Pub-
lication No. 85-230). The Good Samaritan Hospital is accred-
ited by the American Association for Accreditation of Labo-
ratory Animal Care.
A double lumen, twin port catheter was designed for
delivery of fluid to the pericardial space (Kloner/Comedicus).
One port served as the inlet allowing infusion; the second port
continuously removed fluid so that a constantly circulating
system was bathing the heart with either the chilled or the
warm infusate. The lumen utilized for infusion terminated as a
single outlet 3 cm before the tip. Suction of the infusate was
achieved at the distal 3 cm of the tip of the catheter by an
opening at the tip and multiple side holes. The catheter was
prepared for introduction after flushing the two lumens with
heparinized Ringer’s lactate.
Animal preparation. White male New Zealand rabbits
weighing 2.2 to 3.2 kg were anesthetized with intramuscularly
administered xylazine (200 mg) and ketamine (400 mg), intu-
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bated and mechanically ventilated. A deep level of anesthesia
was maintained during the study with pentobarbital (;50 mg/h)
given intraperitoneally. Catheters were placed in the internal
jugular vein for infusion of saline and in the carotid artery for
hemodynamic monitoring and withdrawal of reference blood
samples during regional myocardial blood flow measurements.
A left lateral thoracotomy was performed and the parietal
pericardium was exposed. Without opening the pericardium,
the course of the left circumflex artery or its major branch was
identified for future occlusion. The pericardial catheter was
placed by making a small incision in the parietal pericardium
near the base of the heart. The pericardium around the
catheter was closed by a previously placed purse-string suture,
thus preventing any leaks.
The two ports of the catheter were connected to a closed
circuit tubing system filled with heparinized Ringer’s lactate.
This circuit was passed through a peristaltic pump that per-
fused the pericardial space at a rate of 20 ml/min without net
accumulation of fluid.
Experimental protocol. The rabbits were then randomized
to one of two treatment groups. In the chilled perfusion group
the tubing was passed through an ice water bath to chill the
liquid. In the warm perfusion group the tubing was passed
through a 40°C water bath to warm the fluid to maintain
average rabbit body temperature (39°C). Rectal temperature
was measured at baseline and every 30 min. Body temperature
was maintained by heating pad if necessary. The pericardium was
perfused for 30 min before coronary artery occlusion. Hemo-
dynamic variables were recorded continuously and measured
every 30 min during the entire protocol to identify any early
instability suggestive of tamponade. If bubbles developed in
the system, the tubing was reprimed with heparinized Ringer’s
lactate.
A temperature probe was placed into the myocardium
through the pericardial layers 5 min before occlusion. The
probe tip was inserted horizontally into the myocardium with
the tip in the region expected to become ischemic. The
placement was typically in the anterior, apical region of the
heart, within 0.5 cm of the perfusion catheter. Temperature
measurement of the myocardium using the thermocouple
probe is subject to some technical limitations. The thickness of
the rabbit ventricular wall is ;3 mm. We attempted to insert
the tip of the probe into the midmyocardium; however, the
location of the probe within the wall could not be exactly
determined. It is probable that the temperature measured by
the probe reflected a gradient from epicardial to endocardial
surfaces, because the epicardial surface was being perfused
externally and the endocardial surface is warmed by blood in
the ventricular cavity.
The temperature was recorded. Next, a stitch was taken
through the pericardium, around the previously identified
coronary artery, and the artery was occluded by forming a
snare using a piece of flanged plastic tubing. In a few rabbits,
a coronary vein, because of its proximity to the artery, may also
have been occluded. Leakage from the pericardial cavity
around the sutured areas was prevented by occlusion of the
holes by the flanged end of the plastic tubing.
The rabbits were then subjected to 30 min of coronary
artery occlusion followed by 3 h of reperfusion. At 25 min of
occlusion, the pericardial perfusion was terminated and the
pericardium was opened. A catheter was placed into the left
atrial appendage and secured with a hemostatic clip. Immedi-
ately after catheter placement, radiolabeled microspheres were
injected and a reference blood sample was collected from the
carotid artery at 2.06 ml/min, as described previously (10). This
blood flow measurement confirmed ischemia in the risk area.
After 30 min of coronary artery occlusion, the myocardium was
allowed to reperfuse by releasing the occluding snare. The
presence of reflow was confirmed by repeating regional myo-
cardial blood flow measurements at 30 min in the reperfusion
period. After 3 h of reperfusion the coronary artery was
reoccluded and blue pigment was instilled from the left atrial
catheter to delineate the risk area. Under deep anesthesia the
rabbit was euthanized with 12 mEq of potassium chloride. The
heart was excised from the thoracic cavity and the right
ventricle was trimmed off. The left ventricle was sliced into
multiple cross-sectional slices ;2 mm in thickness. These slices
were photographed to demonstrate the risk zone, unstained by
the blue pigment. Then these slices were incubated in triphe-
nyltetrazolium chloride at 37°C for 10 min. The necrotic
myocardium was identified as pale nonstained areas and
rephotographed. The photographs of the slices demonstrating
the risk and necrotic areas were enlarged and traced. Area of
risk and infarct were calculated after planimetry and expressed
as a proportion of the total left ventricle. Volumes of the risk
and necrotic regions were calculated as described previously
(8). The following end points were measured: rectal tempera-
ture, myocardial temperature, mean arterial blood pressure,
heart rate, regional myocardial blood flow, area at risk and
infarct size.
Statistical analysis. All data are expressed as mean
value 6 SEM. Statistical analyses were performed using SAS
(Version 6.04). Data on the ischemic and necrotic zones,
temperatures and regional myocardial blood flow were evalu-
ated using a two-tailed t test. Analysis of covariance was used
to test for a group effect on the ratio between the necrotic and
ischemic zones. Analysis of variance for repeated measure-
ments was used to evaluate heart rate and mean arterial
pressure.
Results
A total of 27 rabbits were studied. Data are presented here
from the 20 rabbits randomized to chilled (n 5 10) or control
(n 5 10) perfusion. Seven rabbits were excluded. Four rabbits
were excluded at the start of the protocol because the coronary
artery could not be visualized under the intact pericardium. Of
the remaining three, one was excluded because the coronary
artery failed to reperfuse (as determined by regional myocar-
dial blood flow ,0.2 ml/min per g in the previously ischemic
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region 30 min after reperfusion), and two died during the
reperfusion period.
Temperatures. At the beginning of the experiment, the
body temperature was similar in both groups (39.1 6 0.2°C in
chilled and 38.6 6 0.2°C in warm perfusion hearts, p 5 NS). At
30 min of perfusion the myocardial temperature was signifi-
cantly reduced to 34.1 6 0.9°C in the chilled group compared
with 38.9 6 0.4°C in the control group (p , 0.001, as shown in
Fig. 1). Continued pericardial perfusion during occlusion
further reduced the temperature in chilled hearts (31.7 6
1.0°C) when compared with the control hearts (39.0 6 0.4°C),
p , 0.0001. Thus, perfusion of chilled Ringer’s lactate in the
pericardial space successfully lowered temperature by ;5°C
after 30 min of pericardial perfusion and by ;7°C at end of
occlusion.
Infarct size. The data on risk region and infarct size are
shown in Table 1. The variables of mean body weight, left
ventricular weight and the volume of the risk region (expressed
either in weight or as a proportion of the left ventricle) were
comparable between the two groups. Infarct size, expressed as
a proportion of the risk region was reduced by 49% with
pericardial perfusion with chilled Ringer’s lactate (18 6 3%)
compared with control perfusion (35 6 6%, p 5 0.025). On
visual inspection the salvage appeared to occur transmurally.
Analysis of covariance testing for a group effect on the relation
of the amount of tissue becoming necrotic to the amount of
tissue at risk revealed a significant group effect (p , 0.009).
Therefore on average, for any given size risk region, cooled
hearts developed smaller infarcts.
Heart rate and blood pressure. Pericardial perfusion per-
formed using a closed circuit connected to a peristaltic pump
was achieved without any hemodynamic compromise as shown
in Figure 2. Heart rate and mean arterial pressure were similar
in both the chilled and the warm groups during the entire
protocol. Thus, perfusion of chilled Ringer’s lactate was safely
accomplished by this technique.
Regional myocardial blood flow. Regional myocardial
blood flow measurements in both groups performed during
occlusion confirmed very low flow in the ischemic zone (0.05 6
0.02 ml/min per g in chilled vs. 0.03 6 0.01 ml/min per g in
control perfusion, p 5 NS). Measurements repeated at 30 min
of reperfusion demonstrated successful reflow in ischemic
zones in both groups (1.64 6 0.25 ml/min per g in chilled and
2.60 6 0.39 ml/min per g in control hearts, p , 0.05). Although
both of these values are within the normal range for the rabbit
heart, absolute flow at 30 min of reperfusion was lower in the
chilled group.
Discussion
Background. Many interventions have been tested with the
aim of reducing infarct size, yet only a few maneuvers reliably
and consistently reduced myocardial infarct size. These include
early coronary artery reperfusion and ischemic precondition-
ing. Experiences with pharmacologic agents have been vari-
able, depending on the agent used. The technique of topical
regional cardiac hypothermia has led to the most striking
reductions in infarct size that we have observed in the rabbit
myocardial infarction model (even greater than ischemic pre-
conditioning). The technique could be adapted for use as an
adjunct to reperfusion therapy or to protect potentially jeop-
ardized myocardium during minimally invasive cardiac surgery.
However, our previous studies have been done using a tech-
Figure 1. Average rectal temperatures (RT) and myocardial temper-
atures (MT) in the chilled and control groups during baseline, after
30 min of pericardial perfusion and at 25 min of occlusion.
Table 1. Weights, Risk and Infarct Size Data
Variable
Cold
Perfusion
Control
Perfusion
Risk zone/LV (%) 32 6 4 31 6 3
Necrosis/risk zone (%) 18 6 3* 35 6 6
Myocardium at risk (g) 1.23 6 0.21 1.08 6 0.09
Necrotic myocardium (g) 0.28 6 0.10 0.41 6 0.09
LV weight (g) 3.63 6 0.15 3.48 6 0.12
Body weight (kg) 2.6 6 0.1 2.4 6 0.1
*p 5 0.025 cold perfusion versus control perfusion. LV 5 left ventricle,
ventricular.
Figure 2. Changes in average heart rate and mean blood pressure over
time in the chilled and control groups. There were no significant
differences in hemodynamic variables between the two groups. Base 5
baseline; bpm 5 beats/min; Occl 5 occlusion; Perf 5 perfusion; Rep 5
reperfusion.
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nique of directly cooling the heart with an ice and water bag.
For clinical application, methods must be developed to cool
the heart less invasively.
Previous related studies. Evidence from recent animal
studies have shown a favorable outcome in infarct size reduc-
tion from temperature reduction (1–9). Hale and Kloner (8)
from our laboratory have studied the effects of topical regional
hypothermia on infarct size in the rabbit model. Cooling was
achieved by direct application of a bag filled with ice and water
to the risk zone, beginning 20 min before occlusion and lasting
15 min into reperfusion. Reduction of myocardial tempera-
tures by 3.6 6 0.4°C. was associated with a 65% reduction in
infarct size when compared with control rabbits. More recently
we have shown that hypothermia begun after 10 min of
occlusion reduced infarct size by 50% (9).
Results from the present study. In the present study,
chilled Ringer’s lactate perfusion through a pericardial cathe-
ter was shown to successfully reduce myocardial temperatures
by ;5°C at 30 min and by ;7°C at 55 min. At this level of
temperature reduction, no deaths were observed that could be
attributed to ventricular arrhythmia or bradyarrythmia. By
utilizing a peristaltic pump at a set rate accumulation of fluid
in the pericardial space and subsequent tamponade was pre-
vented. Thus, this method successfully lowered myocardial
temperatures and was safe. Moreover, infarct size was signifi-
cantly reduced by 49% in the chilled group when compared
with the control group.
Use of the pericardial space. The pericardial space has
been proposed as an alternate site of delivery of agents to the
heart and coronary arteries. One of the advantages of this
route of administration is an enhanced local effect with re-
duced systemic effects. Hypothermia induced with a technique
similar to ours may be beneficial in reducing necrosis and
providing myocardial protection in patients with coronary
artery disease undergoing bypass surgery without extracorpo-
real circulation. We envision that the pericardial catheter
could be inserted when the chest is first opened or even before
opening the chest with subxyphoid catheter insertion. At the
time the internal mammary artery is isolated and prepared, the
pericardial space and myocardium could be cooled in prepa-
ration for the anastomosis. With safer techniques in imple-
menting this method, this therapy may also have a potential
role as an adjunct to angioplasty or thrombolysis. The advent
of improved technology allowing safer introduction of cathe-
ters into the pericardial space will allow the study of the
potential benefits of hypothermia in similar and other clinical
settings where myocardium is in jeopardy from ischemia insult.
Potential therapeutic applications. Advances in tech-
niques and improvements in technology have allowed cardiac
surgeons to successfully perform minimally invasive coronary
artery bypass graft surgery. The most popular approach is to
perform coronary artery bypass graft surgery on a beating
heart without extracorporeal circulation (11,12). The other
method is to conduct anastomosis on a nonbeating heart with
cardiopulmonary bypass by a percutaneous endovascular aortic
occluder and cardioplegia solution delivery system (13,14).
During anastomosis of the left internal thoracic artery with the
left anterior descending artery on a beating heart, reduction of
cardiac motion is aided by adenosine, which causes brief
asystole (15), pharmacologic bradycardia (16) or vagus nerve
stimulation (17). In addition, many devices have been reported
to stabilize the coronary artery and the adjoining myocardium,
allowing ease of anastomosis (12). However, patients under-
going revascularization on beating hearts may have a limited
tolerance to ischemia and have the potential for great risk of
myocardial damage. Proposed methods of myocardial protec-
tion in such a setting are the benefits of preconditioning by
adenosine (18), Na1-H1 exchange inhibitors like HOE 694
(19) and brief aortic cross clamping before initiating cardio-
pulmonary bypass (20). Many of these methods are currently
under investigation.
Conclusions. A significant reduction in myocardial temper-
ature, without the development of cardiac tamponade, can be
attained using a pericardial catheter to cool the pericardial
space. This reduction in temperature causes a significant
reduction in necrotic damage. This technique might be used to
cool and protect the heart during minimally invasive cardiac
surgery or as an adjunct to thrombolysis.
We are indebted to Thomas C. Hutsell, PhD and James R. Grabek of
Comedicus, Columbia Heights, Minnesota for providing the catheters used in the
present study.
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